GlassScriptPhysician profile
John J Zaro
NPI 1720096571
$1,966.56
in general payments reported to CMS, 2019-2025
19 companies · $202 in 2025
The $202 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $262 · 2021: $454 · 2022: $232 · 2023: $313 · 2024: $234 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $748.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $297.98 | 2020-2025 | Jardiance, Zepbound, Mounjaro |
| Novo Nordisk INC | $286.25 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Amarin Pharma, INC. | $257.07 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $241.04 | 2019-2025 | Zoryve, Livalo |
| Opko Pharmaceuticals, LLC | $185.06 | 2023 | Rayaldee |
| Astrazeneca Pharmaceuticals LP | $123.58 | 2024 | Airsupra |
| Amgen INC. | $118.82 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $91.82 | 2019-2025 | Xifaxan |
| Axsome Therapeutics, INC. | $90.31 | 2023-2024 | Auvelity, Sunosi |
| Teva Pharmaceuticals USA, INC. | $71.48 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.20 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $34.71 | 2021 | |
| Jazz Pharmaceuticals INC. | $27.31 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.50 | 2022 | |
| Merck Sharp & Dohme LLC | $15.48 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $15.00 | 2021 | |
| Radius Health, INC. | $15.00 | 2021 | |
| Almatica Pharma LLC | $14.56 | 2024 | Loreev Xr |
| Pfizer INC. | $12.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Zaro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.